About Hemosphere
Hemosphere is a Healthcare company based in Eden Prairie (United States) founded in 1987, and was acquired by CryoLife in May 2012. Vascular access devices for hemodialysis patients are developed and commercialized. Hemosphere has raised $9.3 million across 1 funding round from investors including Kaiser Permanente Ventures, Three Arch Partners and Affinity Capital Management. Hemosphere offers products and services including HeRO Graft, Super HeRO, Surfacer Inside-Out Access Catheter System, and Centros Hemodialysis Catheters. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Hemosphere, Inc. Its competitors include Cardival Medical, Aziyo Biologics and EKOS Corporation; 3 of its 3 listed competitors have raised funding.
Company details
Hemosphere was founded in 1987 as a medical device company focused on vascular access solutions. Operations center on the development and commercialization of the Hemodialysis Reliable Outflow (HeRO) Graft, designed for patients with failing fistulas, grafts, or catheter dependency due to venous blockages. The company, previously known as GRAFTcath, Inc., rebranded in 2008 and is based in Eden Prairie, United States, serving the hemodialysis sector.
- Total Equity Funding$9.3M (USD)
in 1 rounds
- Latest Funding Round$9.3M (USD), Series A
Mar 2010
- InvestorsKaiser Permanente Ventures
& 7 more
- Acquired byCryoLife
(May 2012)
Products & Services of Hemosphere
Hemosphere offers a comprehensive portfolio of products and services, including HeRO Graft, Super HeRO, Surfacer Inside-Out Access Catheter System, and Centros Hemodialysis Catheters.
Provides subcutaneous access for hemodialysis to reduce infections.
Expands HeRO Graft functionality for improved vascular access.
Facilitates access in patients with venous occlusive disease.
Offers long-term access with self-centering tips for efficiency.
Apps and channels of Hemosphere
its YouTube channel Merit Medical has 16.4K subscribers and 30 videos.
Videos from Hemosphere
The most watched videos on Hemosphere's YouTube channel, Merit Medical (16.4K subscribers). Click a video to play it here.
More on Merit Medical.
Funding Insights of Hemosphere
Hemosphere has successfully raised a total of $9.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $9.3 million completed in March 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.3M
- Total Rounds 1
- Last Round Series A — $9.3M
- First Round $9.3M
(Mar 2010)
- Investors Count 7
All 1 funding rounds of Hemosphere with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2010 | $9.3M | Series A | – | Kaiser Permanente Ventures |
8 investors in total: 8 institutional.
Investors in Hemosphere
Hemosphere has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Kaiser Permanente Ventures, Three Arch Partners and Affinity Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech and Life Sciences focused corporate VC firm investing in the US | kpventures.com | Oakland, United States | ||
Life science & tech focused VC firm investing in companies in the US | threearchpartners.com | San Mateo, United States | ||
| affinitycapitalmanagement.com | ||||
US healthcare companies are invested in stage-agnostically by Cutlass Capital. | cutlasscapital.com | Boston, United States | ||
Strategic investments in healthcare technologies and data innovations. | ascensionventures.org | |||
| mutualcapitalpartners.com | ||||
| sapientcap.com | ||||
Biomedical services focused on aortic technologies are provided by CryoLife. | cryolife.com |
Investor details for Hemosphere
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Hemosphere
3 dated milestones of Hemosphere across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Hemosphere is founded.
- Funding First funding round of $9.3M.
- Exit Acquired by CryoLife.
Competitors of Hemosphere
Hemosphere has 3 listed competitors in our database, 3 of them funded. They include Cardival Medical, Aziyo Biologics and EKOS Corporation.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cardivamedical.com | 2002 | Santa Clara, United States | $169.45M | 158 | A device for vascular access management is developed. | |
| aziyo.com | 2015 | Silver Spring, United States | $49.59M | 162 | Regenerative medicine products are developed for orthopedic and cardiovascular applications. | |
| ekoscorp.com | 1995 | Bothell, United States | $58.8M | Ultrasound thrombolytic devices for pulmonary embolism treatment are developed. |
Detailed competitors of Hemosphere
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Hemosphere (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Hemosphere
Hemosphere was founded in 1987 and raised its 1st funding round 23 years after it was founded.
Hemosphere is headquartered in Eden Prairie, United States. It is registered at Eden Prairie, Minnesota, United States.
Hemosphere is a funded company, having raised a total of $9.3M across 1 funding round to date. The company's 1st funding round was a Series A of $9.3M, raised on Mar 2010.
Hemosphere was founded in 1987 as a medical device company focused on vascular access solutions. Operations center on the development and commercialization of the Hemodialysis Reliable Outflow (HeRO) Graft, designed for patients with failing fistulas, grafts, or catheter dependency due to venous blockages. The company, previously known as GRAFTcath, Inc., rebranded in 2008 and is based in Eden Prairie, United States, serving the hemodialysis sector.
Hemosphere's top competitors include Cardival Medical, Aziyo Biologics and EKOS Corporation.
Hemosphere offers HeRO Graft, Super HeRO, Surfacer Inside-Out Access Catheter System, and Centros Hemodialysis Catheters.
Hemosphere has 8 investors. Key investors include Kaiser Permanente Ventures, Three Arch Partners, Affinity Capital Management, Sapient Capital Partners, and Cutlass Capital.
Hemosphere operates through Hemosphere, Inc.
Yes. Hemosphere was acquired by CryoLife in May 2012.